TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ADUS

Addus HomeCare Corporation

Healthcare · Medical Care Facilities

114.10$ -0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ADUS
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +21.5% +9.7% +4.8% +0.5% -10.5% +8.9% +17.7% +7.6% +19.0% +6.2% +21.7% +25.2% +17.9% +13.0% +10.0% +11.3% +9.1% +23.2%
– +20.1% +9.2% +5.0% -0.3% -5.8% +10.0% +15.6% +7.1% +20.0% +5.3% +22.5% +23.6% +14.7% +10.5% +9.4% +10.3% +8.5% +23.2%
– +24.9% +10.9% +4.3% +2.4% -21.7% +5.8% +23.6% +9.1% +16.2% +9.0% +19.6% +29.6% +26.2% +19.3% +11.1% +13.4% +10.3% +23.2%
– – – – – – – – – – – – – – – – – – –
– +17.8% +15.0% +6.5% +4.8% -30.7% +8.1% +23.4% +14.1% +19.3% -8.7% +36.6% +27.2% +27.0% +11.6% +14.5% +8.2% +10.2% +18.6%
– +15.8% +11.4% +4.7% +3.1% -30.2% +6.9% +25.6% +14.7% +20.7% +1.1% +24.1% +26.8% +25.8% +11.9% +13.6% +7.8% +9.4% +18.7%
– +115.4% +8.5% +1.8% -135.1% – +1.9% +16.9% -11.3% -3.4% +63.2% -9.6% +52.2% +28.1% +48.1% +4.2% +32.3% +12.9% +35.0%
– +17.2% +16.7% -55.6% -16.0% -31.7% -60.9% +3.6% +12.6% +196.7% +91.8% +12.2% -38.1% +2.7% +82.1% +53.4% +24.7% -30.4% +23.9%
– +2,124.0% -1.8% +79.7% -149.7% – +6.2% +16.1% -12.1% +5.7% +30.3% -3.1% +62.6% +26.4% +44.0% -0.4% +35.2% +22.2% +28.3%
– +3,243.8% +30.8% +111.4% -184.0% – -20.7% +42.4% -27.6% +4.2% +125.9% -55.8% +79.7% +19.7% +73.4% -7.4% +33.0% +36.9% +22.4%
– +1,942.1% -10.5% +67.4% -132.9% – +150.8% -36.1% -5.1% +3.5% +13.2% +28.6% +44.2% +31.3% +36.2% +2.0% +35.8% +17.7% +30.3%
– +51.6% -1.8% -3.9% -89.9% +1,037.7% -2.9% +23.1% -5.2% +19.8% +33.3% +2.6% +33.1% +26.2% +41.1% +3.0% +28.2% +13.2% +27.2%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?